Individuals who have experienced significant weight fluctuations earlier in life are more prone to loose skin too, because repeated stretching weakens the skins structure over time
While adipose tissue reduction is therapeutically desirable, disproportionate loss of lean mass may lower resting energy expenditure, impair functional capacity, and potentially compromise long-term metabolic durability
This approach allowed us to examine the relationship between GLP1R expression levels and patient outcomes, and to contextualize these findings within the broader landscape of clinical data on GLP1R agonist use [41, 42]
contains higher doses of semaglutide (up to 2.4 mg weekly) compared to Ozempics maximum 2 mg dose Rybelsus (oral semaglutide): Also from Novo Nordisk, this represents the first oral GLP-1 medication approved for type 2 diabetes in September 2019
the medication made hunger control possible
But also there is a point where the body arrives